101 – 139 of 139
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- 3
- next »
- 2002
-
Mark
Platelets: a new target for gene therapy of haemophilia B.
(
- Contribution to journal › Letter
-
Mark
Von Willebrand's disease caused by compound heterozygosity for a substitution mutation (T1156M) in the D3 domain of the von Willebrand factor and a stop mutation (Q2470X).
(
- Contribution to journal › Article
-
Mark
Rapid intracellular degradation of a truncated mutant protein S (Q522X)
(
- Contribution to journal › Letter
-
Mark
Genetic and phenotypic variability between families with hereditary protein S deficiency
(
- Contribution to journal › Article
-
Mark
Multicentre evaluation of IL Test (TM) Free PS: A fully automated assay to quantify Free Protein S
(
- Contribution to journal › Article
- 2001
-
Mark
Complexes between activated protein C and protein C inhibitor measured with a new method: comparison of performance with other markers of hypercoagulability in the diagnosis of deep vein thrombosis
(
- Contribution to journal › Article
-
Mark
Analytical considerations for free protein S assays in protein S deficiency
(
- Contribution to journal › Article
-
Mark
A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor
(
- Contribution to journal › Article
-
Mark
Extracellular nucleotides ATP and UTP induce a marked acute release of tissue-type plasminogen activator in vivo in man
(
- Contribution to journal › Article
-
Mark
Improved hemoglobin status and reduced menstrual blood loss among female carriers of factor V Leiden--an evolutionary advantage?
(
- Contribution to journal › Letter
-
Mark
No increased risk of venous thrombosis in women taking tranexamic acid
(
- Contribution to journal › Letter
-
Mark
Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism : Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls
(
- Contribution to journal › Article
- 2000
-
Mark
Impact, diagnosis and treatment of von Willebrand disease
(
- Contribution to journal › Article
- 1999
-
Mark
Cyclic nucleotide phosphodiesterases (PDEs): diverse regulators of cyclic nucleotide signals and inviting molecular targets for novel therapeutic agents
(
- Contribution to journal › Article
-
Mark
Factor V Q506 (resistance to activated protein C) and prognosis after acute coronary syndrome
(
- Contribution to journal › Article
-
Mark
The Ala25-Thr mutation in the thrombomodulin gene is not frequent in Swedish patients suffering from ischemic heart disease [9]
(
- Contribution to journal › Letter
-
Mark
Prophylactic infusion regimens in the management of hemophilia
(
- Contribution to journal › Article
-
Mark
Control of smooth muscle cell proliferation - The role of the basement membrane
(
- Contribution to journal › Article
- 1998
-
Mark
A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency
(
- Contribution to journal › Article
-
Mark
A new direct, fast and quantitative enzyme-linked ligandsorbent assay for measurement of free protein S antigen
(
- Contribution to journal › Article
-
Mark
Geographic distribution of the 20210 G to A prothrombin variant
(
- Contribution to journal › Article
- 1997
-
Mark
A novel thrombomodulin gene mutation in a patient suffering from sagittal sinus thrombosis
(
- Contribution to journal › Article
-
Mark
The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls
(
- Contribution to journal › Article
-
Mark
A common thrombomodulin amino acid dimorphism is associated with myocardial infarction
(
- Contribution to journal › Article
-
Mark
von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura
(
- Contribution to journal › Article
-
Mark
Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface
(
- Contribution to journal › Article
- 1996
-
Mark
Experimental haemorrhagic effect of two-domain non-glycosylated tissue factor pathway inhibitor compared to low molecular weight heparin
(
- Contribution to journal › Article
-
Mark
Elevated levels of prothrombin activation fragment 1 + 2 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor V gene (APC-resistance) and/or inherited protein S deficiency
(
- Contribution to journal › Article
- 1995
-
Mark
Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease
(
- Contribution to journal › Article
- 1994
-
Mark
Effect of low molecular weight heparin, dextran and their combinations on experimental venous thrombosis in rabbits
(
- Contribution to journal › Article
-
Mark
Study of the interaction of dextran and enoxaparin on haemostasis in humans
(
- Contribution to journal › Article
-
Mark
Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis : A comparison with low molecular weight heparin
(
- Contribution to journal › Article
-
Mark
High titer inhibitors in severe haemophilia A. A meta-analysis based on eight long-term follow-up studies concerning inhibitors associated with crude or intermediate purity factor VIII products [4]
(
- Contribution to journal › Letter
- 1992
-
Mark
Haplotype analysis of identical factor IX mutants using PCR
(
- Contribution to journal › Article
- 1990
-
Mark
Effects of low molecular weight heparin and unfragmented heparin on induction of osteoporosis in rats
(
- Contribution to journal › Article
- 1987
-
Mark
Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers
(
- Contribution to journal › Article
- 1986
-
Mark
Heparin-induced osteoporosis in rats
(
- Contribution to journal › Article
- 1983
-
Mark
Platelet adhesion in polytetrafluoroethylene (PTFE) vascular grafts in vivo and the influence of increased intramuscular pressure - An experimental model.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- 3
- next »